Felipe Opazo
@opazo.bsky.social
PI at the Uni Medical Center Göttingen (UMG), Founder and CTO of NanoTag Biotechnologies. Using nanobodies for super-resolution microscopy in neurosciences. Opinions are my own.
Happy to tell that I got my tenured professorship at the University Medical Center in Göttingen 🇩🇪!
Grateful for my students, mentors, international collaborators, the @nanotag.bsky.social team, and my family (dog included 🐾). Motivated to keep pushing science, innovation, startups, and education 🌍✨
Grateful for my students, mentors, international collaborators, the @nanotag.bsky.social team, and my family (dog included 🐾). Motivated to keep pushing science, innovation, startups, and education 🌍✨
October 17, 2025 at 3:06 PM
Happy to tell that I got my tenured professorship at the University Medical Center in Göttingen 🇩🇪!
Grateful for my students, mentors, international collaborators, the @nanotag.bsky.social team, and my family (dog included 🐾). Motivated to keep pushing science, innovation, startups, and education 🌍✨
Grateful for my students, mentors, international collaborators, the @nanotag.bsky.social team, and my family (dog included 🐾). Motivated to keep pushing science, innovation, startups, and education 🌍✨
Fantastic talk of @ewerslab.bsky.social with ExM data on Septins and Unroof Cells in #GEF25!
September 28, 2025 at 7:35 AM
Fantastic talk of @ewerslab.bsky.social with ExM data on Septins and Unroof Cells in #GEF25!
🧬 New paper out! We explored why #antibodies have kept their 2 binding sites. Turns out, this “divalence” is crucial for B-cell receptors to sense antigen clustering and trigger immune responses, especially for weak or low-density antigens.
Check full text: doi.org/10.1038/s414...
Check full text: doi.org/10.1038/s414...
August 11, 2025 at 12:44 PM
🧬 New paper out! We explored why #antibodies have kept their 2 binding sites. Turns out, this “divalence” is crucial for B-cell receptors to sense antigen clustering and trigger immune responses, especially for weak or low-density antigens.
Check full text: doi.org/10.1038/s414...
Check full text: doi.org/10.1038/s414...
I am very excited about the invitation of @petrikursula.bsky.social to give a seminar at the Uni Bergen (UiB) 🇳🇴. I’ll share some of our work using @nanotag.bsky.social engineered #nanobodies with erasable signals for multiplexing microscopy. Paper: lnkd.in/een2yCDx Seminar: lnkd.in/esNGXhiv
April 8, 2025 at 2:07 PM
I am very excited about the invitation of @petrikursula.bsky.social to give a seminar at the Uni Bergen (UiB) 🇳🇴. I’ll share some of our work using @nanotag.bsky.social engineered #nanobodies with erasable signals for multiplexing microscopy. Paper: lnkd.in/een2yCDx Seminar: lnkd.in/esNGXhiv
Interesting talks on the Extra Celular Matrix (ECM) session at the German Neuroscience Meeting here in #Göttingen #NWG2025; @neurowissg.bsky.social. Let's see what else is there interesting!
March 27, 2025 at 1:45 PM
Interesting talks on the Extra Celular Matrix (ECM) session at the German Neuroscience Meeting here in #Göttingen #NWG2025; @neurowissg.bsky.social. Let's see what else is there interesting!
My 1st post in bsky is about our latest paper of 2024. Excellent collaboration with @petrikursula.bsky.social @myelincentric.bsky.social & Bradley Zuchero labs. We characterized a set of 🦙 #nanobodies binding myelin protein CNPase. It is online at @jneurochem.bsky.social: dx.doi.org/10.1111/jnc....
December 10, 2024 at 2:27 PM
My 1st post in bsky is about our latest paper of 2024. Excellent collaboration with @petrikursula.bsky.social @myelincentric.bsky.social & Bradley Zuchero labs. We characterized a set of 🦙 #nanobodies binding myelin protein CNPase. It is online at @jneurochem.bsky.social: dx.doi.org/10.1111/jnc....